Transcutaneous Electrical Stimulation and Controlled Heat in People With and Without Diabetes
NCT ID: NCT07063524
Last Updated: 2025-07-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
20 participants
INTERVENTIONAL
2024-05-10
2025-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Electrical Stimulation to Accelerate Wound Healing
NCT03821675
Electrical Stimulation and Expression of VEGF and NO in Diabetic Foot Ulcer
NCT02019082
Effect of Lower Leg Heating and Transcutaneous Electrical Nerve Stimulation on Exercise Capacity in Patients With PAD
NCT03462472
Electrical Stimulation and Expression of VEGF, VEGFR-2, HIF and NO in the Diabetic Foot Ulcer
NCT02432859
Effect of Electromagnetic Field Therapy and Customized Foot Insole on Peripheral Circulation and Ankle-Brachial Pressure Index in Patients With Diabetic Foot Ulcer
NCT07070544
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. Sit comfortably in a reclining chair for 5 minutes while temperature, SPO2, and heart rate are taken, and any further questions can be answered with a pulse oximeter and temperature
a. The procedure for temperature, heart rate, and blood saturation rate will be taken using a Homedics Non-Contact Infrared Thermometer. The infrared beam will be pointed at the subject's forehead at approximately 1 foot away, and within 2 seconds, the temperature will be recorded and time-stamped.
b. Procedure for the Pulse Oximeter- A SPO2 Pulse Oximeter will be placed on the subject's foot. The SPO2 sensors are embedded in the insole. The oxygen saturation level and pulse rate will be documented. The pulse oximeter will be cleaned with isopropyl alcohol before and after each use.
2. Temperature
a. The procedure for taking Room temperature-Reading of the room temperature via the thermostat located in the lab.
3. Once the baseline temperature, SPO2, heart rate, and room temperature are documented, a PPG sensor will be located and embedded in the insole.
a. Procedure for a PPG sensor- A PPG sensor is very similar to the pulse oximeter on the finger. The PPG also works on infrared light, similar to the pulse oximeter, and will data collection throughout the experiment.
4. 5-min of blood perfusion will be recorded at the dominant leg/foot.
a. Procedure for recording blood perfusion- Once the subject's foot is on the insole, recordings of blood perfusion can be made from software. The PPG sensor will have a lead wire that connects to a USB port from the PPG to the computer for the data.
5. A boot will be placed on the patient's dominant leg with the subject still sitting; once comfortable with the boot, 5-more minutes of blood perfusion will be measured
a. Procedure for putting on the boot- This boot is commercially available. The subject will put their foot into a padded insole, and straps will secure the foot and portion that goes up to the knee (picture below). The straps can be fastened to the subject comfort. It should not feel too tight or uncomfortable.
6. After 5 minutes of just the boot, the controlled heat in the boot will be turned on, and blood perfusion will be measured for 5 minutes. The heat will never be higher than 36-38 degrees C.
a. Procedure for using controlled heat in the boot-With in the boot, five thermistors emit heat and are designed to increase heat. Once the heat is turned on, warmth will be felt at the subject foot and leg. The subjects and PI can see a digital readout of the heat on the computer screen. The temperature will not go higher than 38 deg C and be kept in the 36-38 deg C range. Past research has shown that this is a comfortable and safe approach.6-9 But the subjects are in full control of the heat, and the investigators can turn it down if it feels too warm.
7. After 5 minutes of heat, electrical stimulation will be added. It will be turned to an intensity that is comfortable to the subject but not high enough for a muscle contraction. The intensity will never be higher than 20 milliamps.
a. Procedure for Electrical stimulation- An electrical stimulator with non-adhesive electrodes embedded in the insole will be used. 4-electrodes will be activated at the insole at the bottom of the foot. The electrodes are connected to an electrical stimulator. The intensity of the stimulus will never be high enough to cause a muscle contraction and be uncomfortable for the subject. The subject will be asked if they are comfortable and given the option to decrease or increase the stimulus (throughout the data collection). The intensity will never be over 20 mA.
8. This combination of electrical stimulation and heat will last 30 minutes while blood perfusion is measured.
a. The procedure of controlled heat and electrical stimulation software will measure both the input of the heat and electrical stimulation, with the safety of the controlled heat, which will never go above 38 degrees C. The subject will always control the electrical stimulation and never experience any discomfort. The subject should not feel any muscle contraction or go over 20 milliamps with the intensity.
9. After 30 minutes, all elements will be turned off, and a final measurement will be made for 10-min.
1. Recording blood perfusion with electrical stimulation and heat. The electrical stimulation and heat units will be turned off, but the PPG sensors located in the insole will collect blood perfusion readings while the subjects are sitting in a chair.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Blood perfusion
Blood flow at the foot with the application of heat and electrical stimulation
Electrical stimulation
Electrical stimulation with controlled heat during the intervention
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Electrical stimulation
Electrical stimulation with controlled heat during the intervention
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Clinical diagnosis of Type I or Type II diabetes
* Controlled diabetes mellitus (HbA1c ≤ 7%)
Exclusion Criteria
* Current smoker
* Diagnosed neuropathy
* Uncontrolled hypertension (HTN)
* Allergy to tape or electrodes
* Diagnosis of dementia
* History of knee joint replacement
* Significant joint pain (e.g., back, hip, or ankle) that may limit the ability to wear a boot for 60 minutes
* Contraindications to TENS, including:
* Presence of pacemakers
* Dermatological conditions
* Abnormal sensation in the knees
* Severe medical or neurological conditions, including:
* Chronic obstructive pulmonary disease
* Cardiovascular disease
* Arteriosclerosis obliterans
* Cerebrovascular accident
* Lumbar disc disorders (e.g., herniation)
* Rheumatoid arthritis
* Fear of electrical stimulation
45 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Western Michigan University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Massood Atashbar
PI
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Massood Atashbar, PhD
Role: PRINCIPAL_INVESTIGATOR
Western Michigan University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Western Michigan University
Kalamazoo, Michigan, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
201131
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.